Over her career she has served on multiple corporate boards and executed numerous partnerships and investments.
She is a co-founder of Initiate Studios, a life sciences incubator founded in 2020, where she partners with entrepreneurs to launch new companies. Previously Dr. Chapman served as Head of Johnson & Johnson Innovation (NYSE: JNJ) for Western North America, Australia and New Zealand. Prior to that, she led teams at General Electric Company (NYSE: GE), including as Head of Healthcare Investing at GE Ventures and Head of Precision Diagnostics at GE Healthcare. Before GE, she held operational roles in early and growth-stage startups and was a Partner at Mohr Davidow Ventures for over 11 years, gaining extensive experience as an investor and board member for a wide variety of life science technology- and data-enabled companies. She was an early employee at Rosetta Inpharmatics (IPO, then acquired by Merck & Co.) and Incyte Genomics.
Rowan holds a PhD in Biochemistry and Molecular Biology and a BA in Biochemistry from the University of Cambridge, United Kingdom, and carried out post-doctoral research at UCSF.